Anti-IL-6 antibodies preventing the binding of IL-6 complexed with IL6Ralpha to gp130

Details for Australian Patent Application No. 2006332216 (hide)

Owner Merck Patent GmbH

Inventors Lo, Kin-Ming; Way, Jeffrey C.; Liu, Yuan; Gillies, Stephen D.

Agent Davies Collison Cave

Pub. Number AU-A-2006332216

PCT Pub. Number WO2007/076927

Priority 60/755,383 30.12.05 US

Filing date 19 December 2006

Wipo publication date 12 July 2007

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

Event Publications

21 August 2008 PCT application entered the National Phase

  PCT publication WO2007/076927 Priority application(s): WO2007/076927

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006332228-Test apparatus and test method for a PV concentrator module

2006332213-Radiation applicator and method of radiating tissue